We use cookies to better understand how you use our site and to improve your experience by personalizing content. Please review our updated Privacy Policy and Terms of Use. If you accept the use of cookies, please click the "I accept" button.I acceptI declineX
Skip navigational links

Medicare Prescription Drug Benefit Manual — Chapters 5 and 6


Email Alert

March 21, 2007

On March 9, 2007, the Centers for Medicare & Medicaid Services (CMS) released final versions of Chapters 5 and 6 of the Prescription Drug Benefit Manual. In promulgating the final version of the Chapters, CMS considered all of the comments received on the draft Chapters released in September 2006.

Chapter 5 addresses the issues of Benefits and Beneficiary Protections. The Chapter contains information about the following:

  • Part D benefits offered by Part D sponsors
  • Qualified prescription drug coverage (including standard and alternative prescription drug coverage) requirements
  • Incurred / "True Out of Pocket" (TrOOP) Costs
  • Establishment of Prescription Drug Plan sponsor service areas
  • Access standards for covered Part D drugs (including retail, mail-order, specialty pharmacy, and long term care pharmacy access)
  • Out of Network Access
  • Public disclosure to beneficiaries of pricing information for generic versions of covered Part D drugs
  • Privacy, confidentiality, and accuracy of enrollee records.

Chapter 6 addresses Part D Drugs and Formulary Requirements and includes information about the following:

  • Definition of a Part D Drug
  • Part D Drug Exclusions
  • Formulary Requirements for Part D Sponsors
  • Common Acute Care Home Infusion Drugs
  • Summary Tables showing Part D Drugs and Excluded Part D Drugs
  • Medicare Part B Versus Part D Coverage Issues
  • List of Formulary Key Drug Types Exempt from Drug List Review Check
  • Commonly Prescribed Drug Classes For Medicare And Dual Eligible Population

Chapters 5 and 6 may be revised in both periodic and annual updates. The Chapters currently reflect CY 2007 guidance. The Part D Task Force will soon be publishing more detailed guidance on Chapters 5 and 6 of the Prescription Drug Benefit Manual.

To access both Chapters 5 and 6, please click here.

We would like to thank Caroline Wade Blankenship (Miller Stratvert PA, Albuquerque, NM) and Scott Kiepen (Hooper Lundy & Bookman, Inc., San Francisco, CA) for providing this email alert.

© 2018 American Health Lawyers Association. All rights reserved. 1620 Eye Street NW, 6th Floor, Washington, DC 20006-4010 P. 202-833-1100 F. 202-833-1105